Dr. Park Tae-oh demos periorbital RF at Cynosure Lutronic Academy

Dr. Park Tae-oh of Relieve Clinic Seoul gave a live eye-area radiofrequency demonstration in Seoul on June 13 as about 1,400 clinicians watched online and in person. The session underscored growing clinical experience with Cynosure Lutronic’s XERF device, which had topped 2,000 installations worldwide by June 2026.

Why it matters: - Periorbital radiofrequency is one of the most technically demanding areas to treat because the skin is thin and the orbital rim is close to the treatment zone. - The Seoul session showed how clinicians are adapting RF use for harder facial areas as XERF adoption expands. - XERF passing 2,000 installations worldwide signals broader clinical uptake, with experience in Korea still ahead of the U.S. market.

What happened: - Dr. Park Tae-oh, director of Relieve Clinic Seoul, performed a live periorbital RF demonstration at Cynosure Lutronic Academy Korea on June 13. - About 1,400 clinicians watched the session across online and offline attendance. - The conference theme was “XERF: Full Face Custom Design RF.” - The hands-on portion ran from Cynosure Lutronic’s affiliated clinic in Gangnam, Seoul, and was streamed to attendees. - Dr. Park focused on the eye area, where treatment is more difficult because of thin skin and proximity to the orbital rim. - Dr. Park said the difficulty of the area was the point of the session.

The details: - Dr. Jeon Su-il of Jeonsuil Dermatology Clinic covered anatomical considerations in treatment planning. - Dr. Kim Ki-tae of Tae Plastic Surgery Clinic presented on cumulative energy delivery protocols. - XERF is a monopolar radiofrequency device from Cynosure Lutronic and the first platform the company released after its merger. - The device adds a 2 MHz frequency to the 6.78 MHz used by earlier radiofrequency systems. - XERF allows energy depth to be set across three levels. - Treatments are performed without anesthesia. - XERF reached the U.S. market in September 2025, 18 months after its Korean release. - Han Sun-ho, president of commercial operations for Korea and Japan at Cynosure Lutronic, said the platform had passed 2,000 installations worldwide since launch. - Han said installations are concentrated in Asia-Pacific and North America. - Relieve Clinic Seoul, in Apgujeong in Gangnam, has used XERF since it became available in Korea. - The clinic now operates four XERF units. - The clinic says that is the largest number at any single practice in Korea. - Cynosure Lutronic gave Relieve Clinic Seoul its XERF Loyalty Award for the first half of 2026. - The citation credits the manufacturer’s own sales records and the highest cumulative purchase volume of genuine XERF tips in Korea over that period. - Dr. Park said the clinic values the variety of cases treated more than the raw device count. - Dr. Park said clinicians should assess skin thickness, fat distribution and facial structure before choosing energy and direction. - The clinic separates consultation and facial assessment before any session begins. - The clinic says the same device at the same settings can require a different approach depending on the patient’s face. - The clinic positions itself around lower-pain treatment and calls that approach “pain-free treatment.” - Patients are asked about prior experiences and concerns before treatment planning. - Dr. Park said the goal is not zero sensation but to keep pain from becoming the reason a patient skips treatment. - The clinic says overseas patients increasingly research the device before traveling and book during a stay in Korea. - Relieve Clinic Seoul offers consultation and treatment planning in English. - The clinic says outcomes from radio frequency treatment vary by individual and suitability is determined during physician consultation.

Between the lines: - The event functioned as both a clinical demonstration and a signal of product momentum for XERF in its strongest early market. - Relieve Clinic Seoul is using device depth, consultation workflow and pain management as part of its brand positioning, not just as technical features. - The international-patient angle suggests device familiarity can influence medical travel decisions, especially for aesthetic procedures.

What's next: - XERF’s installed base will likely keep expanding as more clinics adopt the platform in Asia-Pacific and North America. - Relieve Clinic Seoul is likely to continue using live demonstrations and English-language consultation to reach both clinicians and overseas patients. - Individual suitability will continue to be determined through physician consultation before treatment.